Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Roger Jeffs
11 Jun 2026
Director
Sold on a plan
286
$249.12
$71.25K
Mark Coleman
10 Jun 2026
Director
Sold on a plan
643
$249.00
$160.11K
Susan Mahony
10 Jun 2026
Director
Sold on a plan
300
$246.18
$73.85K
Roger Jeffs
10 Jun 2026
Director
Sold on a plan
286
$246.18
$70.41K
Susan Mahony
9 Jun 2026
Director
Sold on a plan
300
$237.21
$71.16K
Mark Coleman
2 Jun 2026
Director
Sold on a plan
5,537
$223.39
$1.24M
Mark Coleman
1 Jun 2026
Director
Sold on a plan
6,000
$230.30
$1.38M
Mark Coleman
29 May 2026
Director
Sold on a plan
6,000
$233.46
$1.40M
Mark Coleman
26 Feb 2026
Director
Sold on a plan
25,000
$161.11
$4.03M

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 578,146
History held since 23 Nov 2015